Organovo Holdings, Inc., Tarveda Therapeutics, Inc. - M&A Call Transcript
Good morning. This is the operator, and we are ready to begin the call.
I would like to turn the call over to Taylor Crouch, President and CEO of Organovo.
Thank you, operator. Good morning, and welcome to our conference call which will provide an overview of the proposed merger between Organovo and Tarveda Therapeutics that was announced in a press release that was jointly issued earlier today.
Joining me on the call is the President, CEO and Chairman of Tarveda, Drew Fromkin, and we look forward to discussing with you what we believe to be an exciting development for both our companies.
The call will run as follows. I'll discuss the strategic process Organovo has undertaken to get us to the merger we announced today, provide my thoughts on why Tarveda is the right path forward for our company and our stockholders and touch on some of the key details of the proposed transaction. Drew will then share his perspective on this merger and the opportunity for
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |